Patrick Phelps2025-12-12T18:06:28+00:00SOFIE activates FAPI-PRO, second [18F]FAPI-74 Phase 3 trialPatrick Phelps2025-12-12T18:06:28+00:0012, Dec 2025|
Patrick Phelps2025-11-17T16:54:53+00:00SOFIE activates FAPI-GO, first [18F]FAPI-74 Phase 3 trialPatrick Phelps2025-11-17T16:54:53+00:0017, Nov 2025|
sofie_c557hm2025-10-24T16:14:21+00:00Mosessian Named one of Top 25 Women Chief Scientific Officers in 2025sofie_c557hm2025-10-24T16:14:21+00:0024, Oct 2025|
Patrick Phelps2025-10-15T16:42:09+00:00SOFIE Biosciences Prepares Launch of Two [18F]FAPI-74 Phase 3 Studies, following successful FDA engagementPatrick Phelps2025-10-15T16:42:09+00:001, Oct 2025|
sofie_c557hm2025-10-15T16:42:10+00:00FAPI Symposium at SNMMI Hits its Marksofie_c557hm2025-10-15T16:42:10+00:0022, Jun 2025|
sofie_c557hm2025-10-13T13:30:27+00:00SOFIE Biosciences opens PET Manufacturing Facility, expanding service in Illinois, Missouri, and Indianasofie_c557hm2025-10-13T13:30:27+00:001, Apr 2025|
![SOFIE Biosciences Prepares Launch of Two [18F]FAPI-74 Phase 3 Studies, following successful FDA engagement](https://sofie.com/wp-content/uploads/2025/09/Graphic_EOP2-PR_News-Post-700x441.jpg)
